News & Updates

Show Multimedia Only

Childhood disorders of gut-brain interaction may persist into adulthood

22 Sep 2024

Disorders of gut-brain interaction during childhood may continue until adulthood in some patients, reveals a study, noting that management monitoring should persist into adulthood.

Childhood disorders of gut-brain interaction may persist into adulthood

22 Sep 2024

Virtual palliative care confers quality of life improvements in advanced NSCLC

22 Sep 2024

Telehealth delivery of early palliative care positively affects quality of life in patients with advanced non–small cell lung cancer (NSCLC) the same way an in-person delivery does, according to a study.

Virtual palliative care confers quality of life improvements in advanced NSCLC

22 Sep 2024

Despite risks, uterus transplant yields live births

21 Sep 2024 by

Women with successfully transplanted uterus can conceive and subsequently give birth, although the procedure comes with safety risks for both the recipient and the donor, as shown in a small case study.

Despite risks, uterus transplant yields live births

21 Sep 2024

IBD patients at high myocarditis risk for up to 20 years

21 Sep 2024

The risk of myocarditis appears to be elevated among patients with inflammatory bowel disease (IBD) for ≥20 years following diagnosis, suggests a study in Sweden. However, absolute risks remain low.

IBD patients at high myocarditis risk for up to 20 years

21 Sep 2024

1 in 3 patients with respiratory, sleep disorders have anxiety

21 Sep 2024

Anxiety is highly prevalent among patients with respiratory and sleep disorders, with a prevalence estimate of about 30 percent, according to the results of a meta-analysis.

1 in 3 patients with respiratory, sleep disorders have anxiety

21 Sep 2024

Ponsegromab increases weight in patients with cancer cachexia

21 Sep 2024 by

Use of ponsegromab is associated with increased weight gain and reduced cachexia symptoms in patients with cancer cachexia, according to results of a phase II, randomized, double-blind study.

Ponsegromab increases weight in patients with cancer cachexia

21 Sep 2024

TROPiCS-02: Sacituzumab govitecan offers HRQoL benefits in HR+/HER2- mBC

21 Sep 2024 by

According to patient-reported outcomes (PROs) from the TROPiCS-02 study, sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) chemotherapy is associated with health-related quality of life (HRQoL) benefits across most symptoms and functioning domains among patients with hormone receptor–positive, HER2-negative (HR+/HER2-) metastatic breast cancer (mBC).

TROPiCS-02: Sacituzumab govitecan offers HRQoL benefits in HR+/HER2- mBC

21 Sep 2024

Fibrosis stage higher among people living with HIV and MASLD

20 Sep 2024

The extent of liver fibrosis appears to be higher among people living with HIV (PWH) who have metabolic dysfunction-associated steatotic liver disease (MASLD), despite lower NAFLD activity score (NAS) and less pronounced histological drivers of fibrosis, than among their counterparts who have no HIV, according to a study.